{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T03:21:07Z","timestamp":1779333667578,"version":"3.51.4"},"reference-count":18,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"unspecified","delay-in-days":21,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Science and Technology Innovation Demonstration Project of Hubei Provincial Science and Technology Department","award":["2022BCE031"],"award-info":[{"award-number":["2022BCE031"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2025,4,4]]},"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Non-small cell lung cancer (NSCLC) is a leading cause of cancer-related mortality worldwide, with conventional treatments often limited by radiation resistance, systemic toxicity and poor outcomes in advanced stages. Iodine-125 (I-125) seed implantation, combined with chemotherapy and immunotherapy, has emerged as a promising therapeutic strategy, but its efficacy and safety compared with conventional external beam radiotherapy combined with systemic therapies remain unclear. This systematic review and meta-analysis aims to synthesise the available evidence to evaluate the comparative benefits and risks of these treatment modalities.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and analysis<\/jats:title>\n                  <jats:p>Two reviewers will independently search seven databases\u2014PubMed, Embase, Web of Science and the Cochrane Library\u2014for randomised controlled trials (RCTs). These RCTs should compare the efficacy and safety of I-125 seed implantations combined with chemotherapy and immunotherapy against chemoradiotherapy combined with immunotherapy in patients with NSCLC. The risk of bias in the included studies will be evaluated using the Revised Cochrane risk-of-bias tool V.2. Data synthesis will be conducted using RevMan software. Trial sequential analysis will be applied to the primary outcomes. Additionally, subgroup and sensitivity analyses will be performed to assess the robustness of the findings.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Ethics and dissemination<\/jats:title>\n                  <jats:p>Ethical approval is not required because this study is a secondary analysis of existing data. We will disseminate the findings through peer-reviewed publications.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>PROSPERO registration number<\/jats:title>\n                  <jats:p>CRD42024591684.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-094632","type":"journal-article","created":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T16:05:42Z","timestamp":1745337942000},"page":"e094632","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Efficacy and safety of iodine-125 seed implantations combined with chemotherapy and immunotherapy for patients with non-small cell lung cancer: protocol for a systematic review and meta-analysis"],"prefix":"10.1136","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-8201-2211","authenticated-orcid":false,"given":"Kuanghao","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, The first College of Clinical Medicine science, China Three Gorges University, Yichang, People\u2019s Republic of China"},{"name":"Department of Respiratory and Critical Care Medicine, Yichang Central People Hospital, Yichang, People\u2019s Republic of China"},{"name":"Clinical Medical Research Center for Precision Diagnosis and Treatment of Lung Cancer and Management of Advanced Cancer Pain of Hubei Province, Yichang, People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9650-7188","authenticated-orcid":false,"given":"Hong-yan","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, The first College of Clinical Medicine science, China Three Gorges University, Yichang, People\u2019s Republic of China"},{"name":"Department of Respiratory and Critical Care Medicine, Yichang Central People Hospital, Yichang, People\u2019s Republic of China"},{"name":"Clinical Medical Research Center for Precision Diagnosis and Treatment of Lung Cancer and Management of Advanced Cancer Pain of Hubei Province, Yichang, People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao-yu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, The first College of Clinical Medicine science, China Three Gorges University, Yichang, People\u2019s Republic of China"},{"name":"Department of Respiratory and Critical Care Medicine, Yichang Central People Hospital, Yichang, People\u2019s Republic of China"},{"name":"Clinical Medical Research Center for Precision Diagnosis and Treatment of Lung Cancer and Management of Advanced Cancer Pain of Hubei Province, Yichang, People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-yu","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, The first College of Clinical Medicine science, China Three Gorges University, Yichang, People\u2019s Republic of China"},{"name":"Department of Respiratory and Critical Care Medicine, Yichang Central People Hospital, Yichang, People\u2019s Republic of China"},{"name":"Clinical Medical Research Center for Precision Diagnosis and Treatment of Lung Cancer and Management of Advanced Cancer Pain of Hubei Province, Yichang, People's Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2025,4,22]]},"reference":[{"key":"2025101813560775000_15.4.e094632.1","doi-asserted-by":"crossref","first-page":"56","DOI":"10.31083\/j.fbl2803056","article-title":"Heat Shock Proteins in Non-Small-Cell Lung Cancer-Functional Mechanism","volume":"28","author":"Zhou","year":"2023","journal-title":"Front Biosci (Landmark Ed)"},{"key":"2025101813560775000_15.4.e094632.2","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-020-00407-5"},{"key":"2025101813560775000_15.4.e094632.3","doi-asserted-by":"crossref","first-page":"15056","DOI":"10.3390\/ijms232315056","article-title":"Non-Small Cell Lung Cancer Targeted Therapy: Drugs and Mechanisms of Drug Resistance","volume":"23","author":"Wu","year":"2022","journal-title":"IJMS"},{"key":"2025101813560775000_15.4.e094632.4","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.cllc.2022.08.009","article-title":"Immunotherapy in Advanced NSCLC Without Driver Mutations: Available Therapeutic Alternatives After Progression and Future Treatment Options","volume":"23","author":"Leal","year":"2022","journal-title":"Clin Lung Cancer"},{"key":"2025101813560775000_15.4.e094632.5","doi-asserted-by":"publisher","DOI":"10.1097\/COC.0b013e3181ec63ae"},{"key":"2025101813560775000_15.4.e094632.6","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.rpor.2015.08.001","article-title":"Local failure after primary radiotherapy in lung cancer: Is there a role for SBRT?","volume":"20","author":"Amendola","year":"2015","journal-title":"Rep Pract Oncol Radiother"},{"key":"2025101813560775000_15.4.e094632.7","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-017-0897-6","article-title":"Five-fraction SBRT for ultra-central NSCLC in-field recurrences following high-dose conventional radiation","volume":"12","author":"Repka","year":"2017","journal-title":"Radiat Oncol"},{"key":"2025101813560775000_15.4.e094632.8","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF00176890","article-title":"Endobronchial radiation therapy for obstructing malignancies: ten years\u2019 experience with iridium-192 high-dose radiation brachytherapy afterloading technique in 365 patients","volume":"173","author":"Macha","year":"1995","journal-title":"Lung"},{"key":"2025101813560775000_15.4.e094632.9","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.717180","article-title":"Radioactive Iodine-125 in Tumor Therapy: Advances and Future Directions","volume":"11","author":"Wei","year":"2021","journal-title":"Front Oncol"},{"key":"2025101813560775000_15.4.e094632.10","doi-asserted-by":"crossref","first-page":"403","DOI":"10.5114\/jcb.2022.118117","article-title":"Iodine-125 seeds insertion with trans-arterial chemical infusion for advanced lung cancer: a meta-analysis","volume":"14","author":"Hong","year":"2022","journal-title":"J Contemp Brachytherapy"},{"key":"2025101813560775000_15.4.e094632.11","doi-asserted-by":"crossref","first-page":"1005876","DOI":"10.3389\/fonc.2022.1005876","article-title":"Iodine-125 brachytherapy treatment for newly diagnosed brain metastasis in non-small cell lung cancer: A biocentric analysis","volume":"12","author":"Yang","year":"2022","journal-title":"Front Oncol"},{"key":"2025101813560775000_15.4.e094632.12","doi-asserted-by":"crossref","first-page":"347","DOI":"10.5114\/jcb.2021.106241","article-title":"Analysis of the efficacy and safety of iodine-125 seeds implantation in the treatment of patients with inoperable early-stage non-small cell lung cancer","volume":"13","author":"Chen","year":"2021","journal-title":"J Contemp Brachytherapy"},{"key":"2025101813560775000_15.4.e094632.13","doi-asserted-by":"crossref","first-page":"536","DOI":"10.5114\/jcb.2022.123973","article-title":"Computed tomography-guided iodine-125 radioactive seed implantation in small-cell lung cancer: A retrospective study","volume":"14","author":"Li","year":"2022","journal-title":"J Contemp Brachytherapy"},{"key":"2025101813560775000_15.4.e094632.14","doi-asserted-by":"crossref","DOI":"10.3389\/pore.2024.1611716","article-title":"The role of chemoradiotherapy and immunotherapy in stage III NSCLC","volume":"30","author":"Orosz","year":"2024","journal-title":"Pathol Oncol Res"},{"key":"2025101813560775000_15.4.e094632.15","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/8585035","article-title":"Comparison of Efficacy and Safety of First-Line Treatment Options for Unresectable Stage III Non-Small Cell Lung Cancer: A Retrospective Analysis","volume":"2024","author":"Zhao","year":"2024","journal-title":"Int J Clin Pract"},{"key":"2025101813560775000_15.4.e094632.16","doi-asserted-by":"crossref","DOI":"10.2217\/lmt-2022-0014","article-title":"Real-world outcomes and toxicity of adjuvant chemotherapy in NSCLC: a single-center experience","volume":"12","author":"Cronin","year":"2023","journal-title":"Lung Cancer Manag"},{"key":"2025101813560775000_15.4.e094632.17","doi-asserted-by":"crossref","DOI":"10.1177\/17588359231163798","article-title":"Neoadjuvant immunotherapy in resectable non-small-cell lung cancer","volume":"15","author":"Chen","year":"2023","journal-title":"Ther Adv Med Oncol"},{"key":"2025101813560775000_15.4.e094632.18","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"350","author":"Shamseer","year":"2015","journal-title":"BMJ"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-094632","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T20:56:15Z","timestamp":1760820975000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-094632"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":18,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4,22]]},"published-print":{"date-parts":[[2025,4]]}},"alternative-id":["10.1136\/bmjopen-2024-094632"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-094632","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4]]}}}